Inactive Instrument
Quest PharmaTech Inc Share Price Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 42.28L 29.8L 26.08L 24.03L 22.27L 28Cr 42.96L 2.88Cr 1.12Cr 14Cr 1.12Cr 1.09Cr 48Cr | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 52.14L 36.74L 32.15L 29.63L 27.47L 35Cr 52.98L 3.55Cr 1.38Cr 17Cr 1.38Cr 1.35Cr 59Cr | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -15.38% | - | - | 29.8L | |
| -0.45% | +4.69% | +2.40% | +8.84% | 4.97TCr | |
| +0.25% | +1.70% | +419.39% | +621.71% | 4.05TCr | |
| -0.16% | +8.42% | +28.20% | +63.00% | 3.43TCr | |
| +1.10% | +7.77% | +28.18% | -3.96% | 3.48TCr | |
| +1.31% | -0.56% | +5.12% | +33.90% | 2.7TCr | |
| -0.35% | +0.09% | - | - | 1.66TCr | |
| -3.33% | +3.15% | +71.30% | +131.94% | 1.56TCr | |
| +3.79% | +8.88% | +106.63% | +106.63% | 1.43TCr | |
| -2.93% | -2.25% | +12.13% | +17.53% | 1.38TCr | |
| Average | -0.42% | +4.21% | +84.17% | +122.45% | 2.74TCr | |
| Weighted average by Cap. | -0.45% | +4.59% | +95.62% | +140.79% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -18.01L -12.69L -11.11L -10.24L -9L -12Cr -18.3L -1.23Cr -47.73L -5.94Cr -47.65L -46.62L -21Cr | 49.98L 35.22L 30.82L 28.41L 26.33L 33Cr 50.79L 3.41Cr 1.32Cr 16Cr 1.32Cr 1.29Cr 57Cr |
| Net Debt | 8L 6L 5L 5L 4L 5.32Cr 8L 54.17L 21.07L 2.62Cr 21.03L 20.58L 9.07Cr | 10L 7L 6L 6L 5L 6.59Cr 10.02L 67.17L 26.12L 3.25Cr 26.08L 25.51L 11Cr |
Employees
-
Choose MarketScreener 
